UF Researchers Launch Study on Small Materials That May Have a Big Impact on Protecting Communities From COVID-19
Through a newly-funded National Science Foundation Rapid Response Research, or RAPID grant, researchers in the University of Florida departments of environmental and global health and epidemiology are on a mission to improve personal protective equipment, specifically face masks, that are being widely used to protect health care workers and the broader community from infection with SARS-COV-2, the virus that […]
After Acquisition, Tampa Biotech Firm Looks Toward COVID-19 Vaccine
Serendipity is the word Alan Joslyn uses to describe the meeting and eventual acquisition of a Gainesville-based biotech firm. “It’s not every day all of a sudden a private company falls in your lap that’s working in COVID-19,” said Alan Joslyn, CEO of UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in […]
UF Scientist Uses Work Lessons to Succeed in New Home Working Environment
University of Florida scientist Christopher Vincent is used to working with the unknown to learn new grove management practices. As a University of Florida Institute of Food and Agricultural Sciences plant physiologist, Vincent works to discover how citrus trees can thrive under stressful conditions. Now, during the coronavirus stay-at-home recommendations, he’s applying those skills in […]
UF Health to Provide Coronavirus Test-and-Trace Program to Help Reopen University
University of Florida Health is rolling out plans for a rigorous “test-and-trace” program to support the phased reopening of UF, an expansive data-driven effort that will allow students, faculty, and staff to return to campus as safe as possible while minimizing the risk of infection from the novel coronavirus. The program builds on UF Health’s […]
Oragenics Acquires Noachis Terra Inc., to Develop Its TerraCoV2 NIH-Generated SARS-CoV-2 (COVID 19) Vaccine Candidate Utilizing “Spike Protein”
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced its acquisition of UF Innovate | The Hub resident client Noachis Terra Inc., following its entry into a stock purchase agreement, to develop and […]
Lessons Learned From Treating Sepsis May Help With COVID-19 Treatment, UF Researchers Suggest
The mortality rate of the COVID-19 pandemic has altered the standard process of drug development, amplifying the need for lifesaving treatment and marking the start of the sprint toward a cure or gold standard treatment. In a commentary published in Lancet Respiratory Medicine, UF researchers and their collaborators are looking to the past for answers […]
Just – Evotec Biologics to Collaborate With Ology Bioservices on Antibodies Against Coronavirus
Evotec SE, a drug discovery alliance and development partnership company focused on innovative product approaches with leading pharmaceutical and biotechnology companies, announced that its Seattle-based subsidiary Just – Evotec Biologics, Inc. has entered into a partnership with UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices, Inc., a biologics contract development and […]
Algernon Receives Clearance From Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, is pleased to announce that it has received a “No Objection” letter from Health Canada to proceed with NP-120 (Ifenprodil) COVID-19 Phase 2b/3 multinational clinical trial. The same study protocol is being prepared for submission to the U.S. FDA and Australian regulatory authorities. “The study […]
Working Inside a COVID-19 Research Testing Lab
While you have probably heard of the conception of the high-capacity COVID-19 research lab built within just 10 days by various University of Florida Public Health and Health Professions faculty, staff and students, it is likely you have not been able to get a glimpse of what it is like to work in a COVID-19 […]
COVID-19 Crisis As Catalyst for Telemedicine
The COVID-19 crisis has caused a rapid advance in the use of telemedicine for patients with neurological conditions. In a new Viewpoint article in JAMA Neurology, Michael S. Okun, M.D., chair of the department of neurology in the UF College of Medicine, and co-authors discuss the impact of this change and its potential long-term effect on […]